Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Mesothelioma”

385 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 385 results

Early research (Phase 1)Study completedNCT00165555
What this trial is testing

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 70
Early research (Phase 1)Ended earlyNCT01258868
What this trial is testing

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Who this might be right for
MesoltheliomaEsophageal CancerLung Cancer+2 more
National Cancer Institute (NCI) 44
Not applicableStudy completedNCT02603315
What this trial is testing

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Who this might be right for
Malignant Pleural Mesotheliomas
Ain Shams University 50
Not applicableEnded earlyNCT02613299
What this trial is testing

Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

Who this might be right for
MesotheliomaSolitary Fibrous Tumor of the Pleura
Mayo Clinic 5
Early research (Phase 1)Study completedNCT00280982
What this trial is testing

Dendritic Cell-based Immunotherapy in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Erasmus Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03213301
What this trial is testing

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma, Advanced
Swiss Cancer Institute 42
Not applicableUnknownNCT03290183
What this trial is testing

Confocal Laser Endomicroscopy in Pleural Malignancies

Who this might be right for
Pleural Malignant MesotheliomaThymomaPleural Diseases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Early research (Phase 1)Study completedNCT01119664
What this trial is testing

Combination Gene Transfer and Chemotherapy

Who this might be right for
Mesothelioma
Abramson Cancer Center at Penn Medicine 40
Testing effectiveness (Phase 2)Study completedNCT04177953
What this trial is testing

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

Who this might be right for
Pleural Mesothelioma Malignant
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT00715611
What this trial is testing

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)Ended earlyNCT03175172
What this trial is testing

Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 10
Large-scale testing (Phase 3)Looking for participantsNCT04996017
What this trial is testing

Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)

Who this might be right for
Mesotheliomas Pleural
Gruppo Oncologico Italiano di Ricerca Clinica 162
Early research (Phase 1)Study completedNCT00003263
What this trial is testing

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02611037
What this trial is testing

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaMesothelioma
H. Lee Moffitt Cancer Center and Research Institute 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04287829
What this trial is testing

Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients

Who this might be right for
Mesotheliomas Pleural
The Netherlands Cancer Institute 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Load More Results